Royalty Pharma PLC (RPRX)
27.98
+0.16
(+0.58%)
USD |
NASDAQ |
Apr 24, 16:00
27.98
0.00 (0.00%)
After-Hours: 20:00
Royalty Pharma Cash from Operations (TTM): 2.988B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 2.988B |
September 30, 2023 | 2.785B |
June 30, 2023 | 2.750B |
March 31, 2023 | 2.718B |
December 31, 2022 | 2.144B |
September 30, 2022 | 2.064B |
June 30, 2022 | 1.995B |
March 31, 2022 | 1.952B |
December 31, 2021 | 2.018B |
Date | Value |
---|---|
September 30, 2021 | 2.093B |
June 30, 2021 | 2.132B |
March 31, 2021 | 2.090B |
December 31, 2020 | 2.035B |
September 30, 2020 | 3.136B |
June 30, 2020 | 1.858B |
March 31, 2020 | 1.705B |
December 31, 2019 | 1.667B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
1.667B
Minimum
Dec 2019
3.136B
Maximum
Sep 2020
2.243B
Average
2.090B
Median
Mar 2021
Cash from Operations (TTM) Benchmarks
Viatris Inc | 2.800B |
Walgreens Boots Alliance Inc | 101.00M |
Pacira BioSciences Inc | 154.65M |
Amphastar Pharmaceuticals Inc | 183.50M |
Maravai LifeSciences Holdings Inc | 126.22M |